Results 51 to 60 of about 2,461,179 (149)
Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 5, Page 620-625, November 2024.ABSTRACT Objective To compare the diagnostic performance of different manufacturers' immunoassays for the soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio with that of a point‐of‐care (PoC) test for glycosylated fibronectin (GlyFn) in women with suspected pre‐eclampsia (PE).
I. Y. M. Wah +7 more
wiley +1 more source
Performance of machine‐learning approach for prediction of pre‐eclampsia in a middle‐income country
Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 3, Page 350-357, March 2024.ABSTRACT Objective Pre‐eclampsia (PE) is a serious complication of pregnancy associated with maternal and fetal morbidity and mortality. As current prediction models have limitations and may not be applicable in resource‐limited settings, we aimed to develop a machine‐learning (ML) algorithm that offers a potential solution for developing accurate and ...
J. Torres‐Torres +10 more
wiley +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 2, Page 164-172, February 2024.ABSTRACT Objective Most of the published literature on selective fetal growth restriction (sFGR) has focused on monochorionic twin pregnancies. The aim of this systematic review was to report on the outcome of dichorionic diamniotic (DCDA) twin pregnancies complicated by sFGR.
F. D'Antonio +4 more
wiley +1 more source
同型半胱氨酸、超敏C反应蛋白及脂代谢与妊娠高血压疾病的相关性研究
Zhongguo shiyan zhenduanxue, 2015 目的探讨同型半胱氨酸（Hcy）、超敏C反应蛋白（hs-CRP）及脂代谢指标在妊娠高血压疾病（HDCP）中的应用价值。方法选择妊娠高血压患者90例,其中子痫前期轻度16例,子痫前期重度19例,子痫8例。并随机选取同期健康晚期孕妇36例作妊晚组,健康非孕妇40例作对照组。检测各组Hcy、hs-CRP及脂代谢进行分析。结果HDCP组Hcy、hs-CRP、TG、TC、LDL-C及ApoB水平均高于妊晚组 ...
邱爽, 张会英
doaj
Zhongguo shiyan zhenduanxue, 2018 目的探讨尿蛋白干化学试带法诊断孕妇子痫前期中的应用价值。方法自2014至2016年共772例孕妇纳入研究,对尿蛋白干化学试带法与24h尿蛋白定量进行相关性分析,对尿蛋白干化学试带法诊断孕妇子痫前期能力进行ROC分析 ...
柏明见, 冯京全, 冯璟, 梁国威
doaj
血清IL-6、CRP、TNF-α、PON-1以及APN在子痫诊断中的应用价值
Zhongguo shiyan zhenduanxue, 2020 妊娠期高血压发病率逐年上升,是早产及孕妇和胎儿死亡的主要原因之一[1]。目前对妊娠期高血压以及子痫的诊断主要以血压监测和尿蛋白量检测为依据。因其发病机制不明,治疗主要以降压和保护肾功能以及对症支持治疗为主[2]。既往研究认为炎症介质以及血管内皮损伤可能参与到子痫的发病过程[3]。其中肿瘤坏死因子（TNF-α）、白介素6（IL-6）、C反应蛋白（CRP）、对氧磷酶1（PON-1）以及脂联素（APN）被报道在子痫患者体内呈现差异性表达[4]。
刘宁, 袁宁潞, 王丛, 赵艳晖
doaj
, 1979 癫痫是常见的神经系统疾病之一,癫痫的治疗及其机制的研究受到了广泛的重视。制造动物的实验性癫痫模型是探讨癫痫发病机制,及筛选抗癫痫药物的重要手段之一。 1969年,Goddard发现,对大白鼠脑的某一部分进行短暂的弱电刺激 ...
邵道生, 匡培梓
core +1 more source
Zhongguo shiyan zhenduanxue, 2013 子痫前期是妊娠期高血压疾病的一种,严重威胁母婴健康。近年研究表明妊娠期高血压疾病的发生可能是凝血与抗凝、纤溶机制的改变,血小板激活和血管壁内皮细胞损伤共同作用的结果,使妊娠期高血压疾病患者处于高凝或血栓前状态[1]。本文通过观察和对比重度子痫前期、正常晚期妊娠和非妊娠女性的凝血及血小板指标,揭示它们的变化与重度子痫前期的关系,并探讨其临床意义。
翟宏, 续薇
doaj
[Preeclampsia: An Obstetrician's Perspective]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2022 He GL, Liu XH.
europepmc +1 more source